BM
Bhavin Mukund Mehta
About Bhavin Mukund Mehta
Data last updated:
Bhavin Mukund Mehta is a Whole-Time Director at Kilitch Drugs (India) Limited (since 2007), Director at Pharmaceuticals Export Promotion Council Of India (since 2024) and Director at Monarchy Healthserve Private Limited (since 2014), and holds 3 more current directorships. The companies operate in Pharma, Business Services and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹246 Cr; the largest is Kilitch Drugs (India) Limited at ₹209 Cr (FY 2025). Earlier, Bhavin Mukund Mehta was a Managing Director at Kilitch Healthcare India Limited (2000–2016) and Director at Trigenesis Biosciences Private Limited (2011–2013) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kilitch Drugs (India) Limited L24239MH1992PLC066718 | Whole-Time Director | 29 Sep 2007 | 1992 | ₹209 Cr (FY 2025) | Active |
 Pharmaceuticals Export Promotion Council Of India U24239TG2004NPL043058 | Director | 23 Dec 2024 | 2004 | ₹35.95 Cr (FY 2024) | Active |
 Monarchy Healthserve Private Limited U74999MH2007PTC167204 | Director | 30 Jan 2014 | 2007 | ₹14.6 Lakh (FY 2021) | Active |
| Kilitch Company (Pharma) Limited U24230MH1983PLC030632 | Director | 31 Mar 1998 | 1983 | ₹1.9 Lakh (FY 2023) | Active |
| Nbz Healthcare Llp AAB-5830 | Designated Partner | 13 Jun 2013 | 2013 | Active | |
| Arham Neeta Realities Llp AAB-3856 | Designated Partner | 11 Mar 2013 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kilitch Healthcare India Limited U99999MH1998PLC134973 | Managing Director | 01 Mar 2000 | 1998 | ₹63.63 Cr (FY 2024) | Active |
| Trigenesis Biosciences Private Limited U51900KA2011PTC056703 | Director | 19 Jan 2011 | 2011 | ₹12.6 Lakh (FY 2022) | Active |
 Eye Kare Kilitch Limited U24297MH2009PLC198224 | Director | 31 Dec 2009 | 2009 | Active | |
| Impetus Healthserve Private Limited U74999MH2007PTC173444 | Additional Director | 30 Jan 2014 | 2007 | Amalgamated | |
| Novo Informatics Private Limited U72200DL2011PTC217276 | Director | 10 Jul 2013 | 2011 | ₹3.96 Cr (FY 2022) | Strike Off |
| Nbz It Solutions Limited U72900MH2008PLC180124 | Director | 14 Mar 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhavin Mukund Mehta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavin Mukund Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavin Mukund Mehta
Bhavin Mukund Mehta currently holds 6 directorships: Kilitch Drugs (India) Limited (Whole-Time Director, since 29 Sep 2007, revenue ₹209 Cr (FY 2025)); Pharmaceuticals Export Promotion Council Of India (Director, since 23 Dec 2024, revenue ₹35.95 Cr (FY 2024)); Monarchy Healthserve Private Limited (Director, since 30 Jan 2014, revenue ₹14.6 Lakh (FY 2021)); Kilitch Company (Pharma) Limited (Director, since 31 Mar 1998, revenue ₹1.9 Lakh (FY 2023)); Nbz Healthcare Llp (Designated Partner, since 13 Jun 2013); and 1 more.
Bhavin Mukund Mehta was first appointed on 31 Mar 1998 as Director at Kilitch Company (Pharma) Limited. The most recent appointment on record is 23 Dec 2024 at Pharmaceuticals Export Promotion Council Of India.
The 4 current companies of Bhavin Mukund Mehta that report revenue have a combined latest revenue of ₹246 Cr: Kilitch Drugs (India) Limited ₹209 Cr (FY 2025); Pharmaceuticals Export Promotion Council Of India ₹35.95 Cr (FY 2024); Monarchy Healthserve Private Limited ₹14.6 Lakh (FY 2021); Kilitch Company (Pharma) Limited ₹1.9 Lakh (FY 2023).
Bhavin Mukund Mehta held 6 earlier board appointments: Kilitch Healthcare India Limited (Managing Director, 01 Mar 2000 to 07 Apr 2016); Trigenesis Biosciences Private Limited (Director, 19 Jan 2011 to 20 Feb 2013); Eye Kare Kilitch Limited (Director, 31 Dec 2009 to 07 Apr 2016); Impetus Healthserve Private Limited (Additional Director, from 30 Jan 2014); Novo Informatics Private Limited (Director, from 10 Jul 2013); and 1 more.
The current boards of Bhavin Mukund Mehta's companies include Dipen Jayantilal Jain (Kilitch Drugs (India) Limited), Mira Bhavin Mehta (Kilitch Drugs (India) Limited), Mukund Prataprai Mehta (Kilitch Drugs (India) Limited), Pushpa Nyoupane (Kilitch Drugs (India) Limited), Sunil Sureshji Jain (Kilitch Drugs (India) Limited), Vasudev Krishnamurti (Kilitch Drugs (India) Limited), among others.